PMC:7408073 / 14292-14503 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"505","span":{"begin":129,"end":150},"obj":"Gene"},{"id":"514","span":{"begin":74,"end":77},"obj":"Gene"},{"id":"517","span":{"begin":4,"end":15},"obj":"Disease"}],"attributes":[{"id":"A505","pred":"tao:has_database_id","subj":"505","obj":"Gene:4843"},{"id":"A514","pred":"tao:has_database_id","subj":"514","obj":"Gene:186"},{"id":"A517","pred":"tao:has_database_id","subj":"517","obj":"MESH:D007022"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ve (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving downstream nitric oxide synthase (NOS) pathway activation [38,39,40,41,42,43,44,45,46]. Physi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T121","span":{"begin":4,"end":15},"obj":"Disease"}],"attributes":[{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005468"}],"text":"ve (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving downstream nitric oxide synthase (NOS) pathway activation [38,39,40,41,42,43,44,45,46]. Physi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":165,"end":175},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"ve (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving downstream nitric oxide synthase (NOS) pathway activation [38,39,40,41,42,43,44,45,46]. Physi"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T94","span":{"begin":129,"end":141},"obj":"Chemical"},{"id":"T95","span":{"begin":136,"end":141},"obj":"Chemical"}],"attributes":[{"id":"A94","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_16480"},{"id":"A95","pred":"chebi_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/CHEBI_25741"},{"id":"A96","pred":"chebi_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/CHEBI_29356"}],"text":"ve (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving downstream nitric oxide synthase (NOS) pathway activation [38,39,40,41,42,43,44,45,46]. Physi"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T16","span":{"begin":4,"end":15},"obj":"Phenotype"}],"attributes":[{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002615"}],"text":"ve (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving downstream nitric oxide synthase (NOS) pathway activation [38,39,40,41,42,43,44,45,46]. Physi"}

{"project":"2_test","denotations":[{"id":"32708755-27082314-20678693","span":{"begin":177,"end":179},"obj":"27082314"},{"id":"32708755-29434591-20678694","span":{"begin":183,"end":185},"obj":"29434591"},{"id":"32708755-30554115-20678695","span":{"begin":186,"end":188},"obj":"30554115"},{"id":"32708755-31427727-20678696","span":{"begin":189,"end":191},"obj":"31427727"},{"id":"32708755-20599443-20678697","span":{"begin":195,"end":197},"obj":"20599443"},{"id":"32708755-23249272-20678698","span":{"begin":198,"end":200},"obj":"23249272"}],"text":"ve (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving downstream nitric oxide synthase (NOS) pathway activation [38,39,40,41,42,43,44,45,46]. Physi"}